4-(2,6-dichlorobenzyl)-2-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3(2H)-one

ID: ALA5201988

PubChem CID: 168291960

Max Phase: Preclinical

Molecular Formula: C18H16Cl2N2O2

Molecular Weight: 363.24

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2[nH]c(C)c(Cc3c(Cl)cccc3Cl)c2=O)cc1

Standard InChI:  InChI=1S/C18H16Cl2N2O2/c1-11-14(10-15-16(19)4-3-5-17(15)20)18(23)22(21-11)12-6-8-13(24-2)9-7-12/h3-9,21H,10H2,1-2H3

Standard InChI Key:  XIPWUAOKHPWXQM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.6873    0.0666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3548    0.5515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0998    1.3362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2748    1.3362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0199    0.5515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6873   -0.7584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5124    2.0508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1518    0.3379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3654   -0.4590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820   -1.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9956   -1.8371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7929   -2.0508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3747   -1.4713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1657   -0.6735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7493   -0.0901    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0646   -0.5708    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7771    0.3379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3608    0.9213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1551    0.7076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3687   -0.0896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7894   -0.6712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9916   -0.4624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1657   -0.3031    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7493    0.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  1  6  2  0
  3  7  1  0
  2  8  1  0
  8  9  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
  9 14  1  0
 14 15  1  0
 10 16  1  0
 17  5  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 17 22  1  0
 22 21  2  0
 20 23  1  0
 23 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5201988

    ---

Associated Targets(Human)

PARP14 Tchem Poly [ADP-ribose] polymerase 14 (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.24Molecular Weight (Monoisotopic): 362.0589AlogP: 4.38#Rotatable Bonds: 4
Polar Surface Area: 47.02Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.25CX Basic pKa: 1.16CX LogP: 4.30CX LogD: 3.95
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -1.01

References

1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O..  (2022)  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.,  65  (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281]

Source